Latin American consensus on the treatment of melasma
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17522 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Jorge Ocampo-Candiani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina and Hospital Universitario "Dr. José E. Gonzalez", Servicio de Dermatología, Universidad Autónoma de Nuevo León, Monterrey, N.L,…. Hauptthemen laut MEDLINE: Melanosis, Skin Lightening Preparations. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Melasma is a chronic, relapsing hyperpigmentation disorder that primarily affects photoexposed areas, occurring most frequently in adult women with darker skin phototypes. The primary factors contributing to its development include sun exposure, sex hormones (e.g., pregnancy), and genetic predisposition. Melasma is highly prevalent in Latin America, where many countries lie in intertropical zones and exhibit significant ethnic diversity because of centuries of intermixing among Native Americans, Europeans, and Sub‐Saharan Africans. Nine Latin American experts formulated a DELPHI‐based consensus to develop a valuable approach for treating melasma in this diverse population. After establishing an accurate diagnosis, assessing the impact on quality of life, and determining disease severity, the consensus recommends mitigating known triggers and promoting rigorous photoprotection. Active therapy should be tailored based on individual characteristics (e.g., pregnancy status, previous treatments, skin sensitivity). Treatment options include topical depigmenting agents, systemic therapies, and procedural interventions such as laser therapy, microneedling, and chemical peels. Periodic reassessment of the treatment is essential, with strategies adjusted if targeted outcomes are not achieved. Once clinical remission is attained, patients should continue using topical depigmenting agents and maintain strict photoprotection measures to prevent recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Medicina and Hospital Universitario "Dr. José E. Gonzalez", Servicio de Dermatología, Universidad Autónoma de Nuevo León, Monterrey, N.L, Mexico.
- IDCA Dermatología and Hospital Vivian Pellas, Managua, Nicaragua.
- Universidad Ute-Centro de Alta Especialidad Dermatológica Skinpro, Quito, Ecuador.
- Departamento de Dermatología, Helpharma, CLIPSO (Clínica para el Manejo de Enfermedades Inmunomediadas), Medellin, Colombia.
- Facultad de Medicina, Universidad de Chile, Santiago, Chile.
- Facultad de Medicina and CiruDerm, UNMSM, Lima, Peru.
ORCID-Profile: Jorge Ocampo-Candiani, Fernando Valenzuela-Ahumada, Helio A Miot
Zitieren
APA
Ocampo-Candiani, J., Alas-Carbajal, R., Bonifaz-Araujo, J. F., Marín-Castro, H., Valenzuela-Ahumada, F., Véliz-Barandiarán, J. L., Vila Echague, A., Zepeda-Reyes, D. E., & Miot, H. A. (2025). Latin American consensus on the treatment of melasma. International Journal of Dermatology. https://doi.org/10.1111/ijd.17522
Vancouver
Ocampo-Candiani J, Alas-Carbajal R, Bonifaz-Araujo JF, Marín-Castro H, Valenzuela-Ahumada F, Véliz-Barandiarán JL, et al. Latin American consensus on the treatment of melasma. International Journal of Dermatology. 2025. doi:10.1111/ijd.17522
BibTeX
@article{OcampoCandiani2025,
author = {Ocampo-Candiani, Jorge and Alas-Carbajal, Roberto and Bonifaz-Araujo, Jorge F and Marín-Castro, Hernando and Valenzuela-Ahumada, Fernando and Véliz-Barandiarán, José Luis and Vila Echague, Agustina and Zepeda-Reyes, David E and Miot, Helio A},
title = {Latin American consensus on the treatment of melasma},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17522}
}
EUVIMED